Jasa Marga Tbk (JSMR)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 2,660.00 |
|---|---|
| 52-week range | 1,965.00 – 4,130.00 |
| Return, 1 month / 3 months | −5.0% / −1.5% |
| Return, 1 year / 3 years | −30.2% / −30.3% |
| Trend | Below its 200-day average |
| RSI (14) | 55 |
| Volatility (1 year) | 35.2% |
| Worst drawdown (1 year) | -43.7% |
| Average daily value traded | 9,960.50M IDR |
| Dividend yield | 5.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jasa Marga Tbk is an Indonesian toll road operator based in Jakarta. The company builds, operates and maintains toll roads that connect cities and regions across the country, earning revenue from the tolls paid by drivers of cars, buses and trucks. It also manages rest areas and related roadside services along its highways. Its customers are mainly road users and the transport and logistics businesses that depend on the toll network for travel and freight movement.
Jasa Marga Tbk trades under the code JSMR on the Jakarta Exchange in Indonesia, with its price quoted in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jasa Marga Tbk (JSMR) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 2,660.00 on 23 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 300 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 30.2% and over the last three months it fell 1.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.2% | ||
| From 52-week high | -33.8% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.5% | ||
| 6-month return | -13.7% | ||
| 12-month return, skipping the last month | -26.6% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.7% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 9,960.50M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.9% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +26.1% |
|---|---|
| 1 month | −5.0% |
| 3 months | −1.5% |
| 6 months | −13.7% |
| 1 year | −30.2% |
| 3 years | −30.3% |
| 5 years | −31.8% |
Signals
| 50-day / 200-day average | 2,717.00 / 2,929.76 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 116.66 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Jun 2026 | IDR 156.2292 |
| 20 May 2025 | IDR 156.2292 |
| 21 May 2024 | IDR 37.8635 |
| 22 May 2023 | IDR 75.6939 |
| 22 Jun 2020 | IDR 15.2050 |
| 15 May 2019 | IDR 45.5216 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.